Showing 1 - 17 results of 17 for search 'Rachel S. Crowley', query time: 0.06s
Refine Results
-
1
-
2
Should denosumab treatment for osteoporosis be continued indefinitely? by Jane A. Noble, Malachi J. McKenna, Rachel K. Crowley
Published 2021-04-01
Article -
3
Adherence with reporting of ethical standards in COVID-19 human studies: a rapid review by Lydia O’Sullivan, Ronan P. Killeen, Peter Doran, Rachel K. Crowley
Published 2021-06-01
Article -
4
Extreme hyponatraemia due to primary polydipsia and quetiapine-induced SIAD by Darran Mc Donald, Tara Mc Donnell, Rachel Katherine Crowley, Elizabeth Brosnan
Published 2021-10-01
Article -
5
-
6
Myxoedema coma caused by immunotherapy-related thyroiditis and enteritis by Darran Mc Donald, Eirena Goulden, Garret Cullen, John Crown, Rachel K Crowley
Published 2021-10-01
Article -
7
Double trouble: two cases of dual adrenal pathologies in one adrenal mass by Vasileios Chortis, Christine J H May, Kassiani Skordilis, John Ayuk, Wiebke Arlt, Rachel K Crowley
Published 2019-03-01
Article -
8
-
9
-
10
-
11
Kappa Opioid Receptor Agonist Mesyl Sal B Attenuates Behavioral Sensitization to Cocaine with Fewer Aversive Side-Effects than Salvinorin A in Rodents by Bronwyn M. Kivell, Kelly F. Paton, Nitin Kumar, Aashish S. Morani, Aimee Culverhouse, Amy Shepherd, Susan A. Welsh, Andrew Biggerstaff, Rachel S. Crowley, Thomas E. Prisinzano
Published 2018-10-01
Article -
12
-
13
Quantitative Airway Assessment of Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia (DIPNECH) on CT as a Novel Biomarker by Cormac O’Brien, John A. Duignan, Margaret Gleeson, Orla O’Carroll, Alessandro N. Franciosi, Dermot O’Toole, Aurelie Fabre, Rachel K. Crowley, Cormac McCarthy, Jonathan D. Dodd, David J. Murphy
Published 2022-12-01
Article -
14
The impact of macrosomia on cardiometabolic health in preteens: findings from the ROLO longitudinal birth cohort study by Sophie Callanan, Sarah Louise Killeen, Anna Delahunt, Nessa Cooney, Rosemary Cushion, Malachi J. McKenna, Rachel K. Crowley, Patrick J. Twomey, Mark T. Kilbane, Ciara M. McDonnell, Catherine M. Phillips, Declan Cody, Fionnuala M. McAuliffe
Published 2023-09-01
Article -
15
Benefit of burosumab in adults with X-linked hypophosphataemia (XLH) is maintained with long-term treatment by Karine Briot, Wei Sun, Rachel K Crowley, Maria Luisa Brandi, Stuart H Ralston, Peter Kamenický, Martine Cohen-Solal, Richard Keen, Angela Williams, Muhammad K Javaid, Robin H Lachmann, Annabel Nixon, Mark Nixon, Anne-Lise Lecoq, Sami Kolta, Jennifer S Walsh, Angela J Rylands
Published 2023-02-01
Article -
16
The Intriguing Effects of Substituents in the <i>N</i>-Phenethyl Moiety of Norhydromorphone: A Bifunctional Opioid from a Set of “Tail Wags Dog” Experiments by Meining Wang, Thomas C. Irvin, Christine A. Herdman, Ramsey D. Hanna, Sergio A. Hassan, Yong-Sok Lee, Sophia Kaska, Rachel Saylor Crowley, Thomas E. Prisinzano, Sarah L. Withey, Carol A. Paronis, Jack Bergman, Saadet Inan, Ellen B. Geller, Martin W. Adler, Theresa A. Kopajtic, Jonathan L. Katz, Aaron M. Chadderdon, John R. Traynor, Arthur E. Jacobson, Kenner C. Rice
Published 2020-06-01
Article -
17
Burosumab treatment in adults with X-linked hypophosphataemia: 96-week patient-reported outcomes and ambulatory function from a randomised phase 3 trial and open-label extension by Karine Briot, Rachel K Crowley, Maria Luisa Brandi, Stuart H Ralston, Han-Wook Yoo, Peter Kamenický, Takuo Kubota, Nobuaki Ito, Martine Cohen-Solal, Richard Keen, Angela Williams, Muhammad K Javaid, Hiroyuki Tanaka, Robin H Lachmann, Karl Insogna, Richard Eastell, Yasuhiro Takeuchi, Anthony A Portale, Thomas O Carpenter, Hae Ii Cheong, Yasuo Imanishi, Steven Ing, Suzanne Jan de Beur, Farzana Perwad, Pisit Pitukcheewanont, Thomas J Weber, Annabel Nixon, Mark Nixon, Erik A Imel
Published 2021-11-01
Article